{"ticker": {"uuid": "6805f1e7-14ef-44cc-b66f-00cbdd2e2218", "symbol": "VERU", "name": "Veru Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Veru (NASDAQ: VERU) launches $21.8M at-the-market common stock offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZjVGTWxjbTE1Q3l1MFg1aWItdXdWcVJ5cHc5eUFmM3h3NmFJODk3TUtsQlFrT1Zya3d0RklSa3Fvc2hvUWZUYXE4MW9jV0JkVDhCclUtNEFsb1R5NGo1N1FGdTViazNvR01pTmpub3R1R3h6dC1qUXdiNHN6OUNQWGZMRTZUV2ZnNFVENHpZbFY0UzhSSWRUcEJqZW5Wdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru Inc. (NASDAQ: VERU) to sell up to $21.8M in common stock via ATM", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQkNRM29hQnM3UUhCRWM3aHNMOFgxQlNPSVdSLUszUnRSUXd6WHA5NkJlWWdtbVNPQ0t3a0FhYWVOUUFSN2NGYjRLb0xROF9rbnZaeDZmT1lXRDFEY2N1TFRscmFaZS1GMWFrVVEycE9XMWYzR1ZoVFhSei1tcnFQN0R5WUZKZHZvS3pmSGs3bFc1SXJKTU9rRDhxeHk5RlI3MS0talBYZzBXaDBDSUhBZmIxTDU?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru (NASDAQ: VERU) Stock Price Surges Over 160% After Clinical Supply Deal With Novo Nordisk (NYSE: NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc2dGemtoblB4Y2NIS0hUYU9pMUFfR3h1NlBsMWlHSWxJYW9XWnpaRnozMVRMTGl2eDlsR1VBY2xYYzhvNDNkYk5LYnNBSzhBajFjOEJ2bUFVS0xXaUtjMWdzZXJZdDJLVlhObi13TVZZSWViaHFackp0dWlyOWhWWFBsc1kyQ2gyN2llZjNQTU5fQ3RkdFEtblgya2FKamNsN1laM2QwR0lvOC1zN1l5NlVuZXZ4UUt4R1lGT3d0bm85aVJWRDJObDJmaVVqUGJNN0tlZktvNHFvRUI2cHJ1Rw?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru (NASDAQ: VERU) secures Novo Nordisk Wegovy supply for Phase 2b obesity trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdFM4eTZ3ZFQ1UXNfblVlbzNZSGVINmR6NU1YSDk5WXZvS3E1a1BlcGlYcmw3eUxfdkt1WnZTbDE0V0FISzhOTUxmT2ZLUDk5d2lweTNWT3NxRFhBWkRhWi1NTXhzVnVJakpZSGd4ZS0xakg2Sk8tNTZVQzFWY2pNVFRKZGhfaDRXQ0VKbWZsbFpwU1d3ZWUyVW56THFLQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Veru Inc Q2 2026 shows improved financials", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNQkZ5UXNabXpWbURyLWlNYUp6NXMtOW1zNFMtZHdzZlo4eXdhdlBZdWdYSmtId1pSM28xWnd0eHRuVEFtUVpLOENFZmR6SGcxZXJRc0dIN2NKZmE2YWVvbjR6U001Vm95WFllLVVXc3Y1MG9LbUU1dkNORTVsSkNQdFhXX3hyaGprSk9yUDJYMlJkcUJLd2pfb2lGN3l6M0ZteExMdDNoUUVabW8wRkJ0MlRaa1ltRksyQlZxVWRhZzFjSDRGV3kzeXRZY08?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Veru Inc (VERU) Q2 2026 Earnings Call Highlights: Promising Clinical Trial Results Amid ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/veru-inc-veru-q2-2026-230324085.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T23:03:24+00:00", "published_display": "13 May 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Veru Inc.'s (NASDAQ:VERU) Share Price Boosted 29% But Its Business Prospects Need A Lift Too", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The past three years for Veru (NASDAQ:VERU) investors has not been profitable", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBiM2s4VzhpcEhYeTFyZ1lmQVl0UjBsOWpJcGhZSUZnT0NUN0dQUTdpUWtvemZhOGdYR2FPd1pMS1lLU1dGdTE0Sjd5N3J2Y1Q4ZVI5ZDluc3pzVi1vc0MyZmlyYnZlanduTEhIeFIzcDgzYXdIVGtuWm14aVU4cUE?oc=5", "source_name": "Market source", "published_at": "2024-12-11T08:00:00+00:00", "published_display": "11 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru Inc. to Present at 17th International Conference on Sarcopenia, Cachexia, & Wasting Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOX2ZOd2JpTE9QYlZfcE83TnVTUGU3WXI1Wkw1cGJrM0M3Q2tTemVpa3kxaW5vOFdzNk9aR1JBN1h1TVRnaDdnX1JmOU8ybm1Tc05XTXRyR0tNSU0yYmRIN2pUcmp3dFVvT2dGbHY0Y2xuTGUtWHkwQ1hFd1l1UUpWX094WmFsUml6bzIwUDE1S0hsYnVQODcxYmpkMUhtYTBHVXBpZlJwdmlMX2FocldrcG5HMUtVU19aSG92TjJQQ3NiVUVFNDhRdWQxbHFSdXBaYXFB?oc=5", "source_name": "Quiver Quantitative", "published_at": "2024-11-26T08:00:00+00:00", "published_display": "26 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Veru (NASDAQ: VERU) launches $21.8M at-the-market common stock offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQZjVGTWxjbTE1Q3l1MFg1aWItdXdWcVJ5cHc5eUFmM3h3NmFJODk3TUtsQlFrT1Zya3d0RklSa3Fvc2hvUWZUYXE4MW9jV0JkVDhCclUtNEFsb1R5NGo1N1FGdTViazNvR01pTmpub3R1R3h6dC1qUXdiNHN6OUNQWGZMRTZUV2ZnNFVENHpZbFY0UzhSSWRUcEJqZW5Wdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru Inc. (NASDAQ: VERU) to sell up to $21.8M in common stock via ATM", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQkNRM29hQnM3UUhCRWM3aHNMOFgxQlNPSVdSLUszUnRSUXd6WHA5NkJlWWdtbVNPQ0t3a0FhYWVOUUFSN2NGYjRLb0xROF9rbnZaeDZmT1lXRDFEY2N1TFRscmFaZS1GMWFrVVEycE9XMWYzR1ZoVFhSei1tcnFQN0R5WUZKZHZvS3pmSGs3bFc1SXJKTU9rRDhxeHk5RlI3MS0talBYZzBXaDBDSUhBZmIxTDU?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru (NASDAQ: VERU) Stock Price Surges Over 160% After Clinical Supply Deal With Novo Nordisk (NYSE: NVO)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc2dGemtoblB4Y2NIS0hUYU9pMUFfR3h1NlBsMWlHSWxJYW9XWnpaRnozMVRMTGl2eDlsR1VBY2xYYzhvNDNkYk5LYnNBSzhBajFjOEJ2bUFVS0xXaUtjMWdzZXJZdDJLVlhObi13TVZZSWViaHFackp0dWlyOWhWWFBsc1kyQ2gyN2llZjNQTU5fQ3RkdFEtblgya2FKamNsN1laM2QwR0lvOC1zN1l5NlVuZXZ4UUt4R1lGT3d0bm85aVJWRDJObDJmaVVqUGJNN0tlZktvNHFvRUI2cHJ1Rw?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru (NASDAQ: VERU) secures Novo Nordisk Wegovy supply for Phase 2b obesity trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdFM4eTZ3ZFQ1UXNfblVlbzNZSGVINmR6NU1YSDk5WXZvS3E1a1BlcGlYcmw3eUxfdkt1WnZTbDE0V0FISzhOTUxmT2ZLUDk5d2lweTNWT3NxRFhBWkRhWi1NTXhzVnVJakpZSGd4ZS0xakg2Sk8tNTZVQzFWY2pNVFRKZGhfaDRXQ0VKbWZsbFpwU1d3ZWUyVW56THFLQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Veru Inc Q2 2026 shows improved financials", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNQkZ5UXNabXpWbURyLWlNYUp6NXMtOW1zNFMtZHdzZlo4eXdhdlBZdWdYSmtId1pSM28xWnd0eHRuVEFtUVpLOENFZmR6SGcxZXJRc0dIN2NKZmE2YWVvbjR6U001Vm95WFllLVVXc3Y1MG9LbUU1dkNORTVsSkNQdFhXX3hyaGprSk9yUDJYMlJkcUJLd2pfb2lGN3l6M0ZteExMdDNoUUVabW8wRkJ0MlRaa1ltRksyQlZxVWRhZzFjSDRGV3kzeXRZY08?oc=5", "source_name": "Stocktwits", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru Inc (VERU) Q2 2026 Earnings Call Highlights: Promising Clinical Trial Results Amid ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/veru-inc-veru-q2-2026-230324085.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T23:03:24+00:00", "published_display": "13 May 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru Inc.'s (NASDAQ:VERU) Share Price Boosted 29% But Its Business Prospects Need A Lift Too", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-08T07:00:00+00:00", "published_display": "08 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The past three years for Veru (NASDAQ:VERU) investors has not been profitable", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTFBiM2s4VzhpcEhYeTFyZ1lmQVl0UjBsOWpJcGhZSUZnT0NUN0dQUTdpUWtvemZhOGdYR2FPd1pMS1lLU1dGdTE0Sjd5N3J2Y1Q4ZVI5ZDluc3pzVi1vc0MyZmlyYnZlanduTEhIeFIzcDgzYXdIVGtuWm14aVU4cUE?oc=5", "source_name": "Market source", "published_at": "2024-12-11T08:00:00+00:00", "published_display": "11 Dec 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Veru Inc. to Present at 17th International Conference on Sarcopenia, Cachexia, & Wasting Disorders", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxOX2ZOd2JpTE9QYlZfcE83TnVTUGU3WXI1Wkw1cGJrM0M3Q2tTemVpa3kxaW5vOFdzNk9aR1JBN1h1TVRnaDdnX1JmOU8ybm1Tc05XTXRyR0tNSU0yYmRIN2pUcmp3dFVvT2dGbHY0Y2xuTGUtWHkwQ1hFd1l1UUpWX094WmFsUml6bzIwUDE1S0hsYnVQODcxYmpkMUhtYTBHVXBpZlJwdmlMX2FocldrcG5HMUtVU19aSG92TjJQQ3NiVUVFNDhRdWQxbHFSdXBaYXFB?oc=5", "source_name": "Quiver Quantitative", "published_at": "2024-11-26T08:00:00+00:00", "published_display": "26 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 75, "total_relevant": 17, "sentiment_summary": {"positive": 2, "negative": 2, "neutral": 13, "score": 50, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 79, "events": [{"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 10}, {"event": "general", "label": "Market update", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 2.78, "latest_week": "2026-07-10", "one_week_move": -9.2, "four_week_move": -7.3, "twelve_week_move": 13.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.283871, "market_dynamics_buy_signal": false, "relative_strength": -20.067954, "fair_value_gap": -55.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.0676, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-9.2% over one week, -7.3% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 58, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 6}, {"label": "Stock Titan", "count": 3}, {"label": "simplywall.st", "count": 3}, {"label": "foreignpolicyjournal.com", "count": 1}, {"label": "Stocktwits", "count": 1}, {"label": "GuruFocus.com", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Quiver Quantitative", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 10}, {"label": "Market update", "count": 5}, {"label": "Deals and strategy", "count": 1}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-9.2% over one week, -7.3% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Veru (NASDAQ: VERU) launches $21.8M at-the-market common stock offering"}], "updated_at": "2026-07-16T08:11:18.512269+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}